Quidel Financials
QDEL Stock | USD 42.98 0.77 1.76% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.51 | 0.4876 |
|
| |||||
Current Ratio | 1.49 | 1.5717 |
|
|
The essential information of the day-to-day investment outlook for Quidel includes many different criteria found on its balance sheet. An individual investor should monitor Quidel's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Quidel.
Net Income |
|
Quidel | Select Account or Indicator |
Understanding current and past Quidel Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Quidel's financial statements are interrelated, with each one affecting the others. For example, an increase in Quidel's assets may result in an increase in income on the income statement.
Quidel Earnings Geography
Quidel Stock Summary
Quidel competes with Tandem Diabetes, DexCom, Inspire Medical, Penumbra, and Glaukos Corp. QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company was founded in 1979 and is headquartered in San Diego, California. Quidelortho Corp operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1600 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US74838J1016 |
CUSIP | 74838J101 219798105 |
Location | California; U.S.A |
Business Address | 9975 Summers Ridge |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.quidelortho.com |
Phone | 858 552 1100 |
Currency | USD - US Dollar |
Quidel Key Financial Ratios
Return On Equity | -0.46 | ||||
Profit Margin | (0.66) % | ||||
Operating Margin | 0.07 % | ||||
Price To Sales | 1.03 X | ||||
Revenue | 2.99 B |
Quidel Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 910.9M | 1.9B | 2.4B | 8.9B | 8.6B | 9.0B | |
Other Current Liab | 78.6M | 239.1M | 210.1M | 439.8M | 335.7M | 352.5M | |
Net Debt | 59.5M | (381.4M) | (664.2M) | 2.5B | 2.5B | 2.6B | |
Retained Earnings | 134.7M | 945.0M | 1.6B | 2.2B | 2.2B | 2.3B | |
Cash | 52.8M | 489.9M | 802.8M | 292.9M | 118.9M | 82.3M | |
Net Receivables | 104.9M | 529.2M | 393.8M | 453.9M | 488.4M | 512.8M | |
Inventory | 58.1M | 113.8M | 198.8M | 524.1M | 577.8M | 606.7M | |
Total Liab | 351.0M | 538.5M | 501.0M | 3.9B | 3.6B | 3.7B | |
Total Current Assets | 222.2M | 1.1B | 1.4B | 1.6B | 1.3B | 1.4B | |
Short Term Debt | 19.1M | 7.8M | 10.0M | 207.5M | 166.5M | 174.8M | |
Other Current Assets | 1.9M | 2.2M | 4.6M | 252.1M | 77M | 80.9M | |
Accounts Payable | 26.7M | 86.3M | 101.5M | 283.3M | 294.8M | 309.5M | |
Intangible Assets | 148.1M | 122.4M | 98.7M | 3.1B | 2.9B | 3.1B | |
Good Will | 337.0M | 337.0M | 337.0M | 2.5B | 2.5B | 2.6B | |
Other Assets | 31.6M | 158.8M | 39.7M | 395.8M | 455.2M | 477.9M | |
Long Term Debt | 377.3M | 53.2M | 400K | 2.4B | 2.3B | 2.4B | |
Common Stock | 35K | 39K | 42K | 100K | 115K | 120.8K | |
Other Liab | 127.6M | 96.7M | 48.6M | 294.9M | 339.1M | 356.1M | |
Net Tangible Assets | 167.9M | 973.9M | 1.6B | (666M) | (765.9M) | (727.6M) | |
Capital Surpluse | 363.9M | 425.6M | 388.1M | 279.8M | 321.7M | 290.1M |
Quidel Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 14.8M | 9.6M | 5.7M | 75.7M | 117.5M | 123.4M | |
Total Revenue | 534.9M | 1.7B | 1.7B | 3.3B | 3.0B | 3.1B | |
Gross Profit | 320.8M | 1.3B | 1.3B | 1.9B | 1.3B | 1.3B | |
Operating Income | 52.6M | 1.1B | 906.1M | 843.7M | 246.3M | 258.6M | |
Ebit | 104.2M | 1.0B | 861.2M | 820.5M | 703.3M | 738.5M | |
Ebitda | 104.4M | 1.1B | 915.6M | 1.1B | 703.5M | 738.7M | |
Cost Of Revenue | 214.1M | 312.8M | 427.7M | 1.3B | 1.7B | 1.8B | |
Income Before Tax | 77.2M | 1.0B | 900.4M | 735.9M | (29.1M) | (27.6M) | |
Net Income | 72.9M | 810.3M | 704.2M | 548.7M | (10.1M) | (9.6M) | |
Income Tax Expense | 4.3M | 230.0M | 196.1M | 187.2M | (19M) | (18.1M) | |
Research Development | 52.6M | 84.3M | 95.7M | 190.5M | 246.8M | 259.1M | |
Non Recurring | (14.2M) | (11.7M) | (3.7M) | (9.6M) | (8.6M) | (8.2M) | |
Tax Provision | 4.3M | 230.0M | 196.1M | 187.2M | (19M) | (18.1M) | |
Interest Income | 24.3M | 14.8M | 300K | 1.3M | 5.5M | 8.8M | |
Net Interest Income | (14.8M) | (9.6M) | (5.7M) | (75.7M) | (176.7M) | (167.9M) |
Quidel Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | 9.1M | (54.9M) | (85.0M) | (116.9M) | (211.6M) | (201.0M) | |
Change In Cash | 9.1M | 437.2M | 312.8M | (508.9M) | (174M) | (165.3M) | |
Free Cash Flow | 107.3M | 564.8M | 513.1M | 744.4M | 70.9M | 78.5M | |
Depreciation | 51.8M | 49.1M | 54.4M | 283.6M | 457.2M | 480.1M | |
Other Non Cash Items | 13.5M | 20.6M | (40K) | 57.8M | (72.2M) | (68.6M) | |
Capital Expenditures | 27.2M | 64.9M | 292.7M | 140.9M | 209.3M | 219.8M | |
Net Income | 72.9M | 810.3M | 704.2M | 548.7M | (10.1M) | (9.6M) | |
End Period Cash Flow | 52.8M | 489.9M | 802.8M | 293.9M | 118.9M | 95.9M | |
Change To Netincome | 13.7M | 12.3M | 50.1M | 106.2M | 122.1M | 128.2M | |
Change Receivables | 8.2M | (36.1M) | (402.1M) | 118.9M | 107.0M | 112.3M | |
Net Borrowings | (54.3M) | (511K) | (260K) | 346.2M | 398.1M | 418.0M | |
Investments | (27.2M) | (63.3M) | (63.7M) | (1.6B) | (187.6M) | (197.0M) |
Quidel Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Quidel's current stock value. Our valuation model uses many indicators to compare Quidel value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Quidel competition to find correlations between indicators driving Quidel's intrinsic value. More Info.Quidel is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Quidel's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Quidel by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Quidel Systematic Risk
Quidel's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Quidel volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Quidel correlated with the market. If Beta is less than 0 Quidel generally moves in the opposite direction as compared to the market. If Quidel Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Quidel is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Quidel is generally in the same direction as the market. If Beta > 1 Quidel moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Quidel Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Quidel's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Quidel growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Quidel November 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Quidel help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Quidel. We use our internally-developed statistical techniques to arrive at the intrinsic value of Quidel based on widely used predictive technical indicators. In general, we focus on analyzing Quidel Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Quidel's daily price indicators and compare them against related drivers.
Downside Deviation | 1.9 | |||
Information Ratio | (0.03) | |||
Maximum Drawdown | 14.73 | |||
Value At Risk | (3.05) | |||
Potential Upside | 3.81 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quidel. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Quidel Stock please use our How to buy in Quidel Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quidel. If investors know Quidel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quidel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (27.75) | Revenue Per Share 42.04 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0104 |
The market value of Quidel is measured differently than its book value, which is the value of Quidel that is recorded on the company's balance sheet. Investors also form their own opinion of Quidel's value that differs from its market value or its book value, called intrinsic value, which is Quidel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quidel's market value can be influenced by many factors that don't directly affect Quidel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quidel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quidel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quidel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.